New Insights into Cardiac Nanoparticle Delivery – Decoding Dr. Muzykantov’s Latest Literature Ahead of Our Exclusive Webinar
mybcs
Delivering therapeutic agents to the heart has long been a formidable challenge. While cardiovascular diseases remain the world’s leading cause of mortality, modern therapeutic strategies—including RNA medicines, protein drugs, and gene-editing tools—struggle to reach the myocardium in meaningful amounts. The heart’s unique structural and physiological barriers have historically limited the success of drug delivery systems (DDS), particularly for nucleic acids that require efficient...